

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
He rongoā werohia motuhake te Evinacumab i hangaia hei whakaheke i ngā taumata cholesterol tino tiketike i roto i ngā tāngata e whai ana i tētahi āhuatanga ira onge e kīia ana ko te hypercholesterolemia whānau homozygous (HoFH). He rongoā kaha tēnei e mahi rerekē ana i ngā rongoā cholesterol noa mā te aukati i tētahi pūmua motuhake e ārai ana i tō tinana mai i te tango i te cholesterol kino mai i tō toto.
Mēnā kua tātai koe, tētahi rānei e manaaki ana koe, ki te HoFH, kei te pōuri pea koe i ngā kupu rongoā me ngā kōwhiringa rongoā. He pūtake nui tēnei rongoā mō ngā tāngata e noho mōrearea ana te tiketike o te cholesterol ahakoa te whakamātau i ētahi atu rongoā.
He rongoā paturopi monoclonal te Evinacumab e whāinga ana i tētahi pūmua e kīia ana ko ANGPTL3 (pūmua rite angiopoietin 3). Ko te tikanga, ka raru tēnei pūmua i te kaha o tō tinana ki te wawahi i ngā ngako me te cholesterol i roto i ō toto.
Whakaarohia te ANGPTL3 hei pūwāhi e whakaroa ana i te pūnaha horoi cholesterol māori o tō tinana. Ka tukuna e Evinacumab taua pūwāhi, e āhei ana tō tinana ki te tukatuka me te tango i te cholesterol i te ara whai hua ake. I hangaia motuhake tēnei rongoā mō ngā tāngata e whai ana i te hypercholesterolemia whānau homozygous, tētahi āhuatanga ira onge e pā ana ki te 1 i roto i te 300,000 tāngata puta noa i te ao.
Ka tae mai te rongoā hei otinga mārama, kāore he tae e tukuna ana mā te werohanga i roto i te uaua (IV) tika ki roto i ō toto. E whakarite ana tēnei tikanga tuku i te rongoā ki tō pūnaha i te tere me te mahi i te kaha katoa.
Kua whakaaetia motuhake te Evinacumab hei rongoā i te hypercholesterolemia whānau homozygous (HoFH) i roto i ngā pakeke me ngā tamariki 12 tau me te pakeke ake. He āhuatanga ira nui te HoFH i te wā e tukuna ana e ngā mātua e rua ngā ira hē e whakahaere ana i te tukatuka cholesterol.
Ko te hunga e mate ana i te HoFH te tikanga he 4-6 nga wa teitei ake o te taumata cholesterol LDL i te mea noa, he maha tonu nga wa e neke atu ana i te 400-500 mg/dL. Ko enei taumata tino tiketike ka arahi ki te whakaeke ngakau, te whiu, me etahi atu raruraru ngakau i te wa e tamariki ana, i etahi wa i te tamarikitanga, i nga tau taiohi ranei.
Ka tohua e to taakuta te evinacumab i te wa kaore ano etahi atu rongoa whakaheke cholesterol i whai hua. Kei roto i tenei nga ahuatanga kaore ano i te pai te whakaheke i to cholesterol ki nga taumata haumaru, penei i nga statins, PCSK9 inhibitors, me etahi atu rongoa.
Ka whakamahia te rongoa i te taha o nga huringa kai me etahi atu rongoa whakaheke lipid hei waahanga o te mahere maimoatanga whanui. Ehara i te mea hei whakakapi i etahi atu rongoa engari hei mahi tahi me ratou kia whai hua ai.
Ka mahi a Evinacumab ma te aukati i te ANGPTL3, he pūmua e aukati ana i te tinana mai i te wawahi i nga triglycerides me te cholesterol. Ina aukatihia tenei pūmua, ka taea e to tinana te tango ngako mai i to toto i te huarahi tino pai.
He rongoa kaha rawa tenei mo te whakaheke cholesterol. E whakaatu ana nga rangahau haumanu ka taea e ia te whakaheke i te cholesterol LDL ma te 47% i te toharite, he mea nui tenei mo te hunga kaore ano i pai te urupare ki etahi atu rongoa.
Kaore i rite ki nga statins e mahi ana i roto i to ate ki te whakaiti i te hanga cholesterol, ka mahi a evinacumab i roto i to toto hei awhina i te tango i te cholesterol e rere ana. Ko tenei huarahi rua te take e whakamahia ana i te taha o etahi atu rongoa, kaua ki te whakakapi katoa.
He roa te painga o te rongoa, me ia whakaurunga e whakarato ana i nga painga whakaheke cholesterol mo te marama kotahi. Ko tenei mahi roa te tikanga kaore koe e hiahia ki te rongoa auau, ka taea e koe te whakahaere i to maimoatanga.
Ka tukuna a Evinacumab hei whakauru i roto i te uaua ia whā wiki i te whare hauora, i te pokapū whakauru rānei. Ko te horopeta paerewa he 15 mg mō ia kirokaramu o tō tinana, ka tukuna pōturi ana i roto i te 60 meneti.
Kāore koe e hiahia kia nohopuku, kia karo rānei i te kai i mua i tō whakaurunga. Inaha, mā te kai i te kai māmā i mua ka āwhina i a koe kia pai ake te noho i te wā o te rongoā. He mea whai hua hoki te noho wai mā te inu nui i te wai i mua, i muri i tō whakaurunga.
Ka mātakitaki tata tō rōpū hauora i a koe i te wā o ia whakaurunga, mō te 30 meneti i muri mai. Ka tirohia e rātou ō tohu nui, ka mātakitaki mō ngā urupare tonu. Ko te rūma whakauru te tikanga he pai, ā, ka taea e koe te kawe pukapuka, papa, ētahi atu mahi marie rānei hei whakapau i te wā.
I mua i ia whakaurunga, ka hoatu pea e tō kaiwhakarato hauora he rongoā ki a koe hei ārai i ngā urupare pānga. Kei roto pea i ēnei ko ngā antihistamines, ngā corticosteroids rānei, i runga i ō hiahia takitahi me te hītori hauora.
Ko te tikanga ka whakaarohia a Evinacumab he rongoā wā roa mō te whakahaere i te hypercholesterolemia whānau homozygous. I te mea he āhuatanga ira tūturu te HoFH, e hiahia ana te nuinga o te tangata ki te rongoā tonu hei pupuri i ō rātou taumata cholesterol.
Ka mātakitaki tonu tō tākuta i ō taumata cholesterol, te tikanga ia 3-6 marama, hei aromatawai i te pai o te mahi a te rongoā. Ka tirohia hoki e rātou mō ētahi pānga taha, ka whakatika i tō mahere rongoā whānui i te mea e tika ana.
Ko te whakatau mō te haere tonu i te rongoā e whakawhirinaki ana ki ētahi mea: te pai o te urupare a ō taumata cholesterol, mēnā ka pā tētahi pānga taha nui ki a koe, me tō tūnga hauora whānui. Ko ētahi tāngata ka hiahia pea ki te haere tonu i te rongoā mō ake tonu atu, i te wā e taea ai e ētahi atu te whakaiti i te auau, te whakamātau rānei i ētahi atu huarahi i te wā.
Kaua e mutu te tango i te evinacumab ohorere me te kore e kōrero tuatahi ki tō tākuta. Ka tere te piki o ō taumata cholesterol, ka pōturi pea koe ki te pōrearea o te ngākau.
He pai te whakamanawanui a te nuinga o te tangata ki te evinacumab, engari pērā i ngā rongoā katoa, ka pānga taha. Ko ngā tauhohenga tino noa he ngawari, he mārama hoki me te aroturuki me te manaaki tika.
Anei ngā pānga taha ka tino kitea e koe, me te mahara he iti noa iho ngā raruraru o te nuinga o te tangata ki tēnei rongoā:
Ko ēnei pānga taha noa ka pai ake i roto i ngā rā torutoru, ka iti ake te kite i te urutau o tō tinana ki te rongoā.
Ahakoa he iti noa iho, he pānga taha nui ake e hiahia ana kia āwhina tonu:
E mohio ana tō rōpū hauora ki te tautohu me te whakahaere tere i ēnei urupare. Ka whai rongoā ohorere tonu rātou i te wā o ō rātou whakaurunga, ā, ka whakaako rātou i a koe ki ngā tohu whakatūpato hei mātakitaki i te kāinga.
Kāore a Evinacumab e tika ana mō te katoa, ā, he wāhi motuhake kei reira ka tūtohu tō tākuta kia kaua e whakamahi i tēnei rongoā. Ko te mea nui ko te whai i te tātaritanga kua whakapūmautia o te hypercholesterolemia whānau homozygous, i te mea i hangaia tēnei rongoā mō tēnei āhuatanga onge.
Kāore koe e tika kia whiwhi evinacumab mēnā i pā koe i tētahi urupare pānga nui ki tēnei rongoā, ki ōna wāhanga rānei i mua. Ko ngā tohu o ēnei urupare ko te uaua ki te hā, te pūhi nui, te urupare kiri whānui rānei i hiahiatia ai te rongoā ohorere.
Ka āta arotake tō tākuta mēnā e tika ana tēnei rongoā mōu mēnā he āhuatanga hauora ōna:
Kāore ngā tamariki kei raro i te 12 tau te pakeke e tika kia whiwhi evinacumab, i te mea kāore anō kia whakapūmautia te haumaru me te whai hua i roto i tēnei rōpū tau. Heoi anō, kei te haere tonu te rangahau ki te whakatau mēnā he haumaru, he whai hua rānei mō ngā tamariki nohinohi ake me te HoFH.
Mēnā kei te tango koe i ētahi atu rongoā, ina koa ko ērā e pā ana ki tō pūnaha ārai mate, ki te mahi ate rānei, me āta arotake tō tākuta i ō rongoā katoa i mua i te tīmatanga o te evinacumab.
Ka hokohoko a Evinacumab i raro i te ingoa waitohu Evkeeza i te United States me ētahi atu whenua. Koinei anake te ingoa waitohu e wātea ana mō tēnei rongoā.
Ko te ingoa whānui ko evinacumab-dgnb, hei āwhina i te wehe i tēnei rongoā mai i ētahi atu paturopi monoclonal ka whanake pea ā muri ake nei. Ka whiwhi koe i tō rongoā, ka kite koe i te ingoa "Evkeeza" i runga i te pōkai me ngā pēke whakauru.
Nā te mea he rongoā hou tēnei i whakaaetia i te tau 2021, kāore anō he momo whānui e wātea ana. Ko Regeneron Pharmaceuticals te kamupene e hanga ana i te rongoā, ā, ka tohatohahia mā ngā whare rongoā motuhake me ngā pokapū whakauru.
Ahakoa i hangaia te evinacumab mō te hypercholesterolemia whānau homozygous, he kōwhiringa maimoatanga anō ka whakaarohia e tō tākuta i runga i tō āhuatanga me te pai o tō urupare ki ngā rongoā rerekē.
Ko ngā rongoā tuku iho hei whakaheke i te cholesterol e whakamahia ana i te taha o te evinacumab, hei whakakapi rānei, ko ngā statins teitei pēnei i te atorvastatin, te rosuvastatin rānei. E mahi ana ēnei mā te whakaiti i te hanga cholesterol i tō ate, ahakoa kāore i te kaha i a rātou anō mō te HoFH.
Ko ngā aukati PCSK9 pēnei i te evolocumab (Repatha) me te alirocumab (Praluent) he momo rongoā werohia anō ka taea te whakaheke i te cholesterol. He rerekē te mahi a ēnei i te evinacumab, ā, i ētahi wā ka whakamahia tahi.
Mō ētahi tāngata e mate ana i te HoFH, he kōwhiringa pea te LDL apheresis. He tikanga tēnei e rite ana ki te dialysis e tātarihia ai tō toto hei tango tika i te cholesterol. Ko te tikanga ka mahia ia 1-2 wiki, ā, he tino whai hua, ahakoa he nui ake te wā e pau ana i te rongoā.
Ko ētahi atu rongoā ka uru pea ki tō mahere maimoatanga ko te ezetimibe (Zetia), e aukati ana i te ngongo cholesterol i ō whekau, me ngā kaiwhakawātea waikawa pūtaiao pēnei i te colesevelam (Welchol).
He rerekē te mahi a Evinacumab me ngā aukati PCSK9, nō reira e kore e taea te whakataurite tika. He rongoā whakaheke cholesterol kaha rāua, engari he maha ngā wā e whakamahia ana i roto i ngā āhuatanga rerekē, ā, i ētahi wā ka whakamahia ngātahi.
Ko te tikanga, ka whakamātauhia ngā aukati PCSK9 i te tuatahi nā te mea kua roa rātou e wātea ana, ā, he nui ake ngā raraunga haumaru. Kua whakaaetia hoki rātou mō te whānuitanga o ngā āhuatanga cholesterol, ehara i te HoFH anake. Ka taea e ēnei rongoā te whakaheke i te cholesterol LDL mā te 50-60% i te nuinga o te tāngata.
He painga ahurei a Evinacumab mō te hunga e mate ana i te HoFH. E mahi ana ahakoa kāore i te pai te mahi a ngā kaiwhakawhiwhi LDL, he mea e pā ana ki te HoFH. Mā tēnei ka whai hua mō te hunga kāore i te pai te urupare ki ngā aukati PCSK9, ki ngā statins rānei.
Ko te whiriwhiri i waenga i ēnei rongoā e whakawhirinaki ana ki tō momo ira motuhake o te HoFH, me pēhea tō urupare ki ētahi atu rongoā, me ō āhuatanga hauora takitahi. He maha ngā tāngata e whakamahi ana i ngā momo rongoā e rua ngātahi mō te whakaheke cholesterol nui.
Ka whakaarohia e tō tākuta ngā āhuatanga pēnei i ō taumata cholesterol o nāianei, ngā urupare rongoā o mua, ngā āhuatanga o te noho, me ō hiahia whaiaro i te wā e whakatau ana i te huarahi pai mōu.
Ko te tikanga he haumaru a Evinacumab mō te hunga e mate huka ana, ā, kāore te mate huka e aukati i a koe ki te whakamahi i tēnei rongoā. Inaha, ko te hunga e mate ana i te HoFH me te mate huka e hiahia ana ki te whakahaere cholesterol kaha nā te mea ka whakanuia e te mate huka te tūponotanga o te mate ngākau.
Ka aroturukihia e tō tākuta ō taumata huka toto i te wā e tīmata ana i te evinacumab, nā te mea ka pā te huringa iti ki te whakahaere glucose ki ētahi tāngata. Ko te tikanga he iti ēnei huringa, ā, ka taea te whakahaere mā te whakatikatika i ō rongoā mate huka ki te hiahiatia.
Ko ngā painga o te ngākau e pā ana ki te whakaheke i te kōiwi tino tiketike ka nui ake i ngā pānga iti ki te huka toto. Ka mahi tō rōpū hauora ki a koe ki te whakapai ake i tō whakahaere i te kōiwi me te mate huka i te wā kotahi.
Mēnā ka ngaro i a koe tō whakahaere evinacumab kua whakaritea, whakapā atu ki tō kaiwhakarato hauora, ki te pokapū whakahaere rānei i te wā tonu ki te whakarite anō. Kaua e tatari kia tae rawa ki tō tūpono whakarite i muri mai, nā te mea ka taea e te ngaro i ngā horopeta te piki ake o ō taumata kōiwi.
I te nuinga o te wā, mēnā ka ngaro i a koe tētahi horopeta i roto i ngā rā torutoru noa iho, ka taea e koe te whiwhi i te whakahaere, ā, ka haere tonu ki tō hōtaka marama. Mēnā ka ngaro i a koe tētahi horopeta i roto i te wiki neke atu rānei, tērā pea ka hiahia tō tākuta ki te tirotiro i ō taumata kōiwi i mua i te whakatau i te wā o tō whakahaere e whai ake nei.
Whakamātau ki te whakarite anō i roto i ngā rā torutoru o tō tūpono kua ngaro i te wā e taea ana. E mōhio ana tō rōpū hauora i te wā e puta ana ngā tautohe whakarite, ā, ka mahi tahi rātou ki a koe ki te kimi i tētahi tūpono whakarite watea.
Mēnā ka pā mai ngā pānga taha kino i te wā o tō whakahaere, ka whakamutu tonu te rōpū hauora i te whakahaere, ā, ka whakarato i te rongoā tika. Kua whakangungua rātou ki te whakahaere i ngā tauhohenga whakahaere, ā, he rongoā ohorere kei te wātea tonu.
Mō ngā pānga taha kino e puta ana i muri i tō wehenga atu i te pokapū whakahaere, pērā i te uaua ki te manawa, te pupuhi nui, ngā tohu rānei o te tauhohenga mate pāwera nui, rapua tonu te manaakitanga hauora ohorere. Kaua e tatari kia kite mēnā ka pai ake ngā tohumate i a rātou anō.
Mō ngā pānga taha iti ake engari e pā ana ki te pānga e puta ana i waenga i ngā whakahaere, whakapā atu ki tō kaiwhakarato hauora i ngā hāora pakihi noa. Ka taea e rātou te āwhina ki te whakatau mēnā e pā ana ngā tohumate ki te rongoā me ngā mahi hei mahi i muri mai.
Me whakatau tonu te whakatau ki te whakamutu i te evinacumab i runga i te korero ki to kaiwhakarato hauora. I te mea he mate ira tangata mo te wa katoa te HoFH, he maha nga tangata e hiahia ana ki te rongoa tonu hei pupuri i nga taumata cholesterol haumaru.
Ka whakaaro pea to taakuta ki te whakamutu, ki te whakaiti ranei i te rongoa mena ka pa ki a koe nga paanga kino nui e nui ake ana i nga painga, mena ka pai te whakahaere o ou taumata cholesterol me etahi atu rongoa, mena ka puta mai etahi atu whiringa rongoa.
Ka taea e etahi tangata te whakanui ake i o ratou werohanga i muri i te pumau o o ratou taumata cholesterol, engari kei runga tenei i te urupare takitahi, me mahi anake i raro i te tirotiro hauora.
Ae, ka taea e koe te whiwhi kano kano i te wa e tango ana i te evinacumab. Kare tenei rongoa e tino pehi i to punaha aukati penei i etahi atu rongoa, no reira he haumaru, he mea tūtohu nga kano kano.
Heoi, he pai tonu te whakamohio atu ki to kaiwhakarato hauora mo nga kano kano e whakamahere ana koe ki te whiwhi. Ka tūtohu pea ratou ki te waahi i nga kano kano i waenga i nga werohanga, ki te aro turuki ranei i a koe i muri mai, ina koa mo nga kano kano ora.
He mea nui te noho whakahou tonu me nga kano kano e taunakitia ana mo nga tangata e mate mau tonu ana penei i te HoFH, na te mea ka kino pea nga mate i te hauora ngakau me nga oko toto.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.